NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
AMSTERDAM, THE NETHERLANDS, and IRVINE, CA, May 29, 2012 – Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, announced today that it will present nine posters on genomic research studies in Read More
RASTER: First-Ever Prospective Diagnostic Study in Breast Cancer
RASTER Five-Year Follow-Up Data Indicates Chemotherapy May Be Safely Withheld for Patients Deemed ‘Low Risk’ for Breast Cancer Recurrence Using Agendia’s MammaPrint Test, Data Presented at European Breast Cancer Conference IRVINE, CA and AMSTERDAM, THE Read More
Agendia Wins 2011 Scrip Award for “Best Partnership Alliance”
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, FEBRUARY 29, 2012 – Agendia, an innovative molecular cancer diagnostics company, today announced that the company is a recipient of the 2011 Scrip Award for “Best Partnership” for its Read More







